Current insights into cellular senescence and myotoxicity induced by doxorubicin.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of sports medicine"
DOI: 10.1055/a-1797-7622
Abstract: Doxorubicin is an anti-neoplasmic drug that prevents DNA replication but induces senescence and cellular toxicity. Intensive research has focused on strategies to alleviate the doxorubicin-induced skeletal myotoxicity. The aim of the present review is to… read more here.
Keywords: senescence myotoxicity; current insights; cellular senescence; myotoxicity ... See more keywords